Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

SARS-CoV-2 Nucleocapsid IgG ELISA Kit

For identifying the immune response to SARS-CoV-2 infection

WARNING: This product can expose you to chemicals including Silica, which is [are] known to the State of California to cause cancer.  For more information go to www.P65Warnings.ca.gov.
Catalog #: E4903
$695.00

Product Details

Cat # +Size E4903-100
Size 100 assays
Kit Summary BioVision’s SARS-CoV-2 Nucleocapsid IgG ELISA Kit is an enzyme-linked immunosorbent assay intended for identifying the immune response to SARS-CoV-2 infection. The assay uses the nucleocapsid protein as a bait to capture anti-SARS-CoV-2 antibodies in diluted plasma or serum samples. Subsequent reaction with an enzyme-labeled anti-human-IgG conjugate and a colorimetric substrate generates color, which is proportional to the amount of anti-N antibodies. The presence of anti-SARS-CoV-2 N antibodies (IgG) is determined by comparing the absorbance (OD450 nm) reading of the sample to the OD450 nm reading of the negative control serum. A positive reaction suggests prior SARS-CoV-2 infection.
Detection Method Absorbance at 450 nm
Species Reactivity Human
Applications • Determination of prior SARS-CoV-2 infection
• Study of epidemiology, prevalence and morbidity of COVID-19
• Screening of SARS-CoV-2 infection rate in a given population
Features & Benefits • The assay is a quick, easy and accurate method for determination of recent SARS-CoV-2 infection.
• The assay does not require collection or handling of infectious virus.
• A valuable tool to study COVID-19 epidemiology, prevalence and morbidity.
Kit Components • Nucleocapsid Protein-Coated ELISA Plate
• Wash Buffer (10X)
• Sample Diluent
• Anti-IgG-HRP Conjugate (1000X)
• Positive Control Serum
• Negative Control Serum
• TMB Substrate
• Stop Solution
• Plate Sealing Film
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Coronaviruses are large, lipid-enveloped, single-stranded RNA viruses known to infect a wide array of hosts, including humans, bats, mice and other mammals. Amongst the seven known human coronaviruses, MERS-CoV, SARS-CoV-1 and SARS-CoV-2 are the most pathogenic, causing severe, potentially fatal respiratory and cardiovascular symptoms. The emergence of the novel SARS-CoV-2 virus, the cause of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic, has proven to be the greatest public health crisis of the 21st Century. SARS-CoV-2 has a ~30 kb genome that encodes 29 proteins, including 4 structural proteins used in virion assembly, namely the Envelope (E), Membrane (M), Spike (S) and Nucleocapsid (N) proteins. The N protein is a RNA-binding protein that maintains the viral genomic RNA in a conformation required for viral RNA transcription and replication. The N protein amino-terminal contains the RNA-binding Domain, a potential structural target for novel antiviral drugs. The N protein is a highly immunogenic antigen, with specific anti-N protein antibodies detected in patient serum 5-10 days following infection. BioVision’s SARS-CoV-2 Nucleocapsid IgG ELISA Kit is an enzyme-linked immunosorbent assay intended for identifying the immune response to SARS-CoV-2 infection. The assay uses the nucleocapsid protein as a bait to capture anti-SARS-CoV-2 antibodies in diluted plasma or serum samples. Subsequent reaction with an enzyme-labeled anti-human-IgG conjugate and a colorimetric substrate generates color, which is proportional to the amount of anti-N antibodies. The presence of anti-SARS-CoV-2 N antibodies (IgG) is determined by comparing the absorbance (OD450 nm) reading of the sample to the OD450 nm reading of the negative control serum. A positive reaction suggests prior SARS-CoV-2 infection. Positive control serum containing a recombinant human monoclonal anti-SARS-CoV-2 N antibody is included in the kit for validation. The assay is a quick, easy and accurate method of indicating recent or prior SARS-CoV-2 infection that does not require collection or handling of infectious virus. This kit is a valuable tool to study the COVID-19 epidemiology, prevalence and morbidity.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.